Snow Software
Private Equity Round in 2017
Snow Software is a technology intelligence company that specializes in asset management software aimed at helping organizations effectively manage their technology consumption. Its platform offers comprehensive visibility and insight into software, SaaS, hardware, and cloud resources. By automating the reconciliation of license entitlements with actual software installations and monitoring both cloud and on-premise usage, Snow Software enables clients to optimize their software licenses and reduce costs. Additionally, the platform features mobile license management, user authentication, and advanced analytics, which equip IT leaders with the necessary tools to enhance performance and operational agility in a hybrid work environment.
Medicure is a specialty pharmaceutical company focused on the development and commercialization of therapeutics for the U.S. hospital market. Medicure’s vision is to become a leading specialty pharmaceutical company that improves the lives of patients while delivering value for its shareholders. The Company’s current focus is in the area of acute cardiovascular care, a market served by its commercial product, AGGRASTAT (tirofiban HCl). The Company is also looking to develop and acquire additional hospital products. To accomplish this, the Company is leveraging its historical expertise in clinical development as well as exploring acquisition opportunities with growth potential. Medicure was established in 1997, and spent its first decade focused on research and development. In 2008, the Company began a transition to focus on its commercial, specialty pharmaceutical business. This new direction was solidified in October 2013 with the U.S. FDA approval of the new label for AGGRASTAT. The label change has provided a basis for the Company to grow sales and achieve profitability, and also to pursue development and acquisition opportunities. Medicure’s board and management is committed to building value for its existing shareholder base and is patiently pursuing a long-term view to establishing the Company as a leading, international pharmaceutical company - one that is distinguished by its unique fit within the contemporary market. Medicure Inc. is based in Winnipeg, Canada and publicly traded on the Toronto Stock Exchange Venture under the symbol MPH. Its subsidiaries include Medicure International, Inc. (Barbados), which owns the U.S. rights to AGGRASTAT, as well as two U.S. corporations, Medicure USA, Inc. and Medicure Pharma, Inc., which distributes the Company’s products in the United States. Medicure Inc. and Medicure USA have a minority interest and fixed option to acquire the holding companies of Apicore LLC and Apicore US LLC (collectively, Apicore). Apicore is a developer and manufacturer of specialty Active Pharmaceutical Ingredients (APIs) and generic products (ANDAs).
Hired Limited, established in 2018 and headquartered in London, operates an online career marketplace that connects tech talent globally with innovative companies seeking recruits. The platform facilitates efficient hiring by providing candidates with objective guidance throughout interviews from dedicated Talent Advocates, enabling side-by-side opportunity comparisons for confident decision-making. Employers gain access to a curated pool of interested candidates and insights into competing offers, streamlining the recruitment process significantly compared to traditional methods.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.